India - English - Central Drugs Standard Control Organization

intra lab - granisetron hcl. - tab/syr - 1mg/1mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - mannitol - iv infusion - 20 gm/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson natural product ltd. (unani) - sharbat atfal - liquid

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

shennong animal health (malaysia) sdn. bhd. - levamisole hydrochloride -

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - ezetimibe; simvastatin (contains butylhydroxyanisole (bha) 0.01%) - tablet - ezetimibe 10.000mg; simvastatin (contains butylhydroxyanisole (bha) 0.01%) 10.000mg

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - ezetimibe; simvastatin (contains butylhydroxyanisole (bha) 0.01%) - tablet - ezetimibe 10.000mg; simvastatin (contains butylhydroxyanisole (bha) 0.01%) 20.000mg

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg - film coated tablet - 10 mg - active: atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg - film coated tablet - 20 mg - active: atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg - film coated tablet - 40 mg - active: atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg - film coated tablet - 80 mg - active: atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.